Proteins

Items 11-20 of 29

Page
per page
Set Descending Direction
  1. FasL (human) (multimeric) (rec.)
    AG-40B-0130
    AG-40B-0130-C01010 µg
    CHF 380.00
    AG-40B-0130-30103 x 10 µg
    CHF 760.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of FasL (human) (multimeric) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Prod. No.
  2. FasL, Soluble (human) (rec.)
    AG-40B-0001
    AG-40B-0001-C01010 µg
    CHF 190.00
    AG-40B-0001-30103 x 10 µg
    CHF 385.00
  3. Fc (human):FasL, Soluble (human) (rec.)
    AG-40B-0132
    AG-40B-0132-C01010 µg
    CHF 335.00
    AG-40B-0132-30103 x 10 µg
    CHF 670.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of MegaFasL, Soluble (human) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Pr
  4. Fc (human):Grancalcin (human) (rec.)
    AG-40B-0242
    AG-40B-0242-C05050 µg
    CHF 440.00
  5. Fn14 (human):Fc (human) (rec.)
    AG-40B-0034
    AG-40B-0034-C05050 µg
    CHF 300.00
    AG-40B-0034-30503 x 50 µg
    CHF 600.00
  6. Netrin-1 (human) (rec.)
    AG-40B-0040
    AG-40B-0040-C01010 µg
    CHF 300.00
    AG-40B-0040-30103 x 10 µg
    CHF 600.00
    AG-40B-0040-C100100 µg
    CHF 1'320.00
  7. NF-κB (p50) (human) (rec.) (His) (highly active)
    AG-40T-0021
    AG-40T-0021-C0022 µg
    CHF 450.00
  8. NF-κB (p65) (human) (rec.) (His) (highly active)
    AG-40T-0020
    AG-40T-0020-C0022 µg
    CHF 390.00
  9. SuperKillerTRAIL™, Soluble (human) (rec.)
    AG-40T-0002
    AG-40T-0002-C02020 µg
    CHF 400.00
    AG-40T-0002-30203 x 20 µg
    CHF 800.00
  10. SuperKillerTRAIL™, Soluble (mouse) (rec.)
    AG-40T-0004
    AG-40T-0004-C02020 µg
    CHF 420.00
    AG-40T-0004-30203 x 20 µg
    CHF 990.00
    SuperKillerTRAIL™, Soluble (mouse) (rec.)

Items 11-20 of 29

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.